---
title: Coagulation and Hemostasis
description: "### Coagulation and Hemostasis in Dogs and Cats ### Physiology of Hemostasis Hemostasis is a critical physiological process that prevents excessive blood loss following vascular injury. It consists of three primary phases: 1. **Primary Hemostasis** – This phase involves the…"
url: "https://anesthesiabraintrust.org/docs/coagulation-and-hemostasis/"
updated: "2025-02-27"
category: Knowledge Home / Case Studies / Cardiovascular
---

# Coagulation and Hemostasis

### Coagulation and Hemostasis in Dogs and Cats

### Physiology of Hemostasis

Hemostasis is a critical physiological process that prevents excessive blood loss following vascular injury. It consists of three primary phases:

1. **Primary Hemostasis** – This phase involves the initial response to vessel injury, where platelets adhere to the exposed subendothelial matrix and aggregate to form a temporary platelet plug. Key components include von Willebrand factor (vWF), platelet activation, and shape change.
2. **Secondary Hemostasis** – This phase is characterized by the activation of the coagulation cascade, leading to the formation of a stable fibrin clot. It involves intrinsic, extrinsic, and common pathways, with key coagulation factors such as Factor VIII, IX, X, and fibrinogen.
3. **Fibrinolysis** – The final phase involves clot breakdown to restore normal blood flow. Plasminogen is converted to plasmin, which degrades fibrin into fibrin degradation products (FDPs), including D-dimers.

### Coagulation Cascade in Dogs and Cats

The coagulation cascade consists of:

- **Intrinsic Pathway**: Initiated by contact with negatively charged surfaces (e.g., Factor XII, XI, IX, and VIII)
- **Extrinsic Pathway**: Initiated by tissue factor (TF) and Factor VII
- **Common Pathway**: Involves Factor X, V, II (prothrombin), I (fibrinogen), and XIII

### Normal Coagulation Values in Dogs and Cats

Coagulation parameters are used to assess hemostasis in veterinary patients. Normal values vary slightly between dogs and cats:

| Test | Dog (Normal Range) | Cat (Normal Range) |
| --- | --- | --- |
| Platelet Count (10^3/μL) | 200-500 | 300-800 |
| Buccal Mucosal Bleeding Time (BMBT) (min) | <4 min | <3 min |
| Activated Clotting Time (ACT) (sec) | 60-120 sec | 60-100 sec |
| Prothrombin Time (PT) (sec) | 7-10 sec | 8-12 sec |
| Activated Partial Thromboplastin Time (aPTT) (sec) | 12-18 sec | 14-20 sec |
| Fibrinogen (mg/dL) | 150-400 | 100-300 |
| D-dimers (μg/mL) | <0.5 | <0.5 |

### Abnormal Coagulation Ranges

Abnormal coagulation values may indicate various disorders:

- **Thrombocytopenia (Platelet count <150,000/μL)**: May be caused by immune-mediated thrombocytopenia (IMTP), bone marrow disease, or disseminated intravascular coagulation (DIC).
- **Prolonged BMBT (>4 min in dogs, >3 min in cats)**: Suggests platelet dysfunction (e.g., von Willebrand disease, thrombocytopathies).
- **Prolonged PT (>12 sec in dogs, >14 sec in cats)**: May indicate vitamin K deficiency, anticoagulant rodenticide toxicity, or liver dysfunction.
- **Prolonged aPTT (>18 sec in dogs, >20 sec in cats)**: Suggests intrinsic pathway defects (e.g., hemophilia A or B, severe liver disease).
- **Elevated D-dimers (>0.5 μg/mL)**: Indicates fibrinolysis and may be associated with DIC, thromboembolic disease, or sepsis.

### Coagulation Disorders in Dogs and Cats

Several inherited and acquired conditions can affect coagulation:

### Inherited Coagulopathies

- **Von Willebrand Disease (vWD)**: Affects platelet adhesion due to deficient or defective von Willebrand factor. More common in certain dog breeds (Doberman Pinschers, Shetland Sheepdogs).
- **Hemophilia A (Factor VIII deficiency)**: X-linked disorder leading to prolonged aPTT.
- **Hemophilia B (Factor IX deficiency)**: Similar to hemophilia A but rarer.

### Acquired Coagulopathies

- **Disseminated Intravascular Coagulation (DIC)**: A systemic, life-threatening condition characterized by excessive coagulation and fibrinolysis.
- **Rodenticide Toxicity**: Involves vitamin K antagonists leading to prolonged PT and aPTT.
- **Liver Disease**: The liver produces most clotting factors; hepatic insufficiency can prolong PT and aPTT.
- **Immune-Mediated Thrombocytopenia (IMTP)**: An autoimmune disorder that destroys platelets, leading to prolonged bleeding.

### Monitoring Techniques for Coagulation

Several diagnostic tests are used to evaluate coagulation in veterinary medicine:

### Laboratory Tests

- **Platelet Count**: Performed using automated hematology analyzers or manual smear evaluation.
- **Buccal Mucosal Bleeding Time (BMBT)**: Assesses primary hemostasis by making a standardized incision and measuring the time to clot formation.
- **Activated Clotting Time (ACT)**: Measures the time required for whole blood to clot after exposure to a surface activator.
- **Prothrombin Time (PT)**: Evaluates the extrinsic and common pathways.
- **Activated Partial Thromboplastin Time (aPTT)**: Assesses the intrinsic and common pathways.
- **Fibrinogen Levels**: Measured using heat precipitation or quantitative assays.
- **D-dimers and FDPs**: Markers of fibrinolysis and useful in diagnosing DIC or thromboembolic disease.

### Point-of-Care (POC) Testing

- **Coagulation analyzers** such as thromboelastography (TEG) and rotational thromboelastometry (ROTEM) provide real-time assessment of clot formation, stability, and breakdown.
- **Viscoelastic Coagulation Testing**: Offers dynamic information about clot strength and fibrinolysis.

### Treatment of Coagulation Disorders

Management of coagulation disorders depends on the underlying cause:

- **Vitamin K1 Therapy**: Used in anticoagulant rodenticide toxicity.
- **Fresh Frozen Plasma (FFP)**: Contains coagulation factors and is used for DIC, hemophilia, and liver disease.
- **Cryoprecipitate**: Enriched in Factor VIII and von Willebrand factor; used for hemophilia A and vWD.
- **Platelet-Rich Plasma (PRP) or Whole Blood Transfusion**: Indicated in cases of severe thrombocytopenia or hemorrhage.
- **Antifibrinolytic Agents**: Such as aminocaproic acid, used to control excessive bleeding.
- **Heparin or Low-Molecular-Weight Heparin (LMWH)**: Employed in thromboembolic conditions.

### Conclusion

Hemostasis and coagulation in dogs and cats are complex processes that require precise regulation. A variety of diagnostic tests are available to monitor coagulation status, and understanding normal and abnormal values is essential for diagnosing and treating coagulopathies effectively.

### References

1. Brooks, M. B., Catalfamo, J. L., & Raymond, S. L. (2014). "Advances in veterinary coagulation testing." *Veterinary Clinics of North America: Small Animal Practice*, 44(6), 1261-1278.
2. de Laforcade, A. M., Freeman, K. P., Shaw, S. P., & Rozanski, E. A. (2016). "Coagulation disorders in small animals." *Journal of Veterinary Emergency and Critical Care*, 26(1), 19-31.
3. Mischke, R., & Pohling, J. (2017). "Hemostatic disorders in dogs and cats." *Tierarztliche Praxis Ausgabe K*, 45(5), 305-317.
4. Scherk, M. A., & Laflamme, D. P. (2015). "Feline coagulation and hemostatic disorders." *Journal of Feline Medicine and Surgery*, 17(1), 10-26.
5. Weiss, D. J., & Wardrop, K. J. (2010). "Schalm's Veterinary Hematology." Wiley-Blackwell.